PHGE

BiomX Inc

Halal Rating :
Comfortable
Last Price $0.74 Last updated:
Market Cap -
7D Change 2.72%
1 Year Change 229.18%

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Biological Products
  • Except Diagnostic Substances
Exchange
Next Earnings Date

BiomX Inc. is a clinical-stage microbiome company developing both natural and engineered phage therapies that target specific pathogenic bacteria. The company focuses on developing treatments for diseases related to microbiome dysfunction, including inflammatory bowel disease, primary sclerosing cholangitis, colorectal cancer, atopic dermatitis, and acne.

The company's primary business model involves research, development, and potential commercialization of phage-based therapeutic products. Their technology platform enables them to develop precision phage cocktails designed to target and destroy harmful bacteria that affect human health.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio

Company Impact

Help us evaluate BiomX Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Recent News & Updates